First Time Loading...

Jasper Therapeutics Inc
NASDAQ:JSPR

Watchlist Manager
Jasper Therapeutics Inc Logo
Jasper Therapeutics Inc
NASDAQ:JSPR
Watchlist
Price: 23.95 USD -2.32% Market Closed
Updated: Jun 11, 2024

Jasper Therapeutics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jasper Therapeutics Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Jasper Therapeutics Inc
NASDAQ:JSPR
Accrued Liabilities
$7.9m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.1B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.8B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
28%

See Also

What is Jasper Therapeutics Inc's Accrued Liabilities?
Accrued Liabilities
7.9m USD

Based on the financial report for Dec 31, 2023, Jasper Therapeutics Inc's Accrued Liabilities amounts to 7.9m USD.

What is Jasper Therapeutics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
46%

Over the last year, the Accrued Liabilities growth was 55%. The average annual Accrued Liabilities growth rates for Jasper Therapeutics Inc have been 46% over the past three years .